Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Musculoskeletal Disorders
Published in: BMC Musculoskeletal Disorders 1/2017

Open Access 01-12-2017 | Research article

Effect of teriparatide (rh-PTH 1–34) versus bisphosphonate on the healing of osteoporotic vertebral compression fracture: A retrospective comparative study

Authors: Akira Iwata, Masahiro Kanayama, Fumihiro Oha, Tomoyuki Hashimoto, Norimasa Iwasaki

Published in: BMC Musculoskeletal Disorders | Issue 1/2017

Login to get access

Abstract

Background

Teriparatide (recombinant human parathyroid hormone 1–34) is increasingly used for the treatment of severe osteoporosis because it stimulates bone formation and may potentially enhance fracture healing. The objective of this study was to investigate the effects of teriparatide versus a bisphosphonate on radiographic outcomes in the treatment of osteoporotic vertebral compression fractures (OVCF).

Methods

A total of 98 patients undergoing non-operative treatment for recent single-level OVCF were reviewed retrospectively. Thirty-eight patients were treated by a once-daily subcutaneous injection of 20 micrograms of teriparatide (TPD group), whereas 60 patients received 35 mg of alendronate weekly (BP group). Except for these medications, the same treatment protocol was applied to both groups. The radiographic assessments included union status, vertebral kyphosis, and mid-vertebral body height. The rates of fracture site surgical intervention were also compared between the two groups. The mean follow-up period was 27 months (median 22.5, range 2 – 75 months).

Results

Cox regression analysis showed that TPD reduced the time-to-union (adjusted relative hazard ratio: 1.86, 95% C.I.: 1.21 – 2.83). The union rate at six months after treatment was 89% in the TPD group and 68% in the BP group; the surgical intervention rate was significantly higher in the TPD group (p = 0.026, adjusted odds ratio: 8.15, 95% C.I.: 2.02 – 43.33). The change in local kyphosis was 4.6° in the TPD group and 3.8° in the BP group (p = 0.495, paired t-test). The change of mid-vertebral body height was 4.4 mm in the TPD group and 3.4 mm in the BP group (p = 0.228, paired t-test). Fracture site surgical interventions were not required in the TPD group; however, two patients in the BP group eventually underwent surgical treatment for symptomatic non-union or vertebral collapse.

Conclusions

This retrospective study suggests that teriparatide may enhance fracture healing and improve the union rate in OVCF.
Literature
1.
Sato M, Grasser W, Endo N, Akins R, Simmons H, Thompson DD, Golub E, Rodan GA. Bisphosphonate action - alendronate localization in Rat bone and effects on osteoclast ultrastructure. J Clin Investig. 1991;88(6):2095–105.CrossRefPubMedPubMedCentral
2.
Peter CP, Cook WO, Nunamaker DM, Provost MT, Seedor JG, Rodan GA. Effect of alendronate on fracture healing and bone remodeling in dogs. J Orthop Res. 1996;14(1):74–9.CrossRefPubMed
3.
4.
Molvik HH. Bisphosphonates and their influence on fracture healing: a systematic review. Osteoporos Int. 2015;26(4):1251–60.CrossRefPubMed
5.
Dempster DW, Cosman F, Parisien M, Shen V, Lindsay R. Anabolic actions of parathyroid-hormone on bone. Endocr Rev. 1993;14(6):690–709.PubMed
6.
Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Investig. 1999;104(4):439–46.CrossRefPubMedPubMedCentral
7.
Dobnig H, Turner RT. Evidence that intermittent treatment with parathyroid-hormone increases bone-formation in adult-rats by activation of bone lining cells. Endocrinology. 1995;136(8):3632–8.PubMed
8.
Hoshino M, Nakamura H, Terai H, Tsujio T, Nabeta M, Namikawa T, Matsumura A, Suzuki A, Takayama K, Takaoka K. Factors affecting neurological deficits and intractable back pain in patients with insufficient bone union following osteoporotic vertebral fracture. Eur Spine J. 2009;18(9):1279–86.CrossRefPubMedPubMedCentral
9.
Pappou IP, Papadopoulos EC, Swanson AN, Cammisa FP, Girardi FP. Osteoporotic vertebral fractures and collapse with intravertebral vacuum sign (Kummel's disease). Orthopedics. 2008;31(1):61–6.CrossRefPubMed
10.
Ito YY. Pathogenesis and diagnosis of delayed vertebral collapse resulting from osteoporotic spinal fracture. Spine J. 2002;2(2):101–6.CrossRefPubMed
11.
Heini PF. The current treatment--a survey of osteoporotic fracture treatment. Osteoporotic spine fractures: the spine surgeon's perspective. Osteoporos Int. 2005;16 Suppl 2:S92.
12.
Wardlaw DD. Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. Lancet. 2009;373(9668):1016–24.CrossRefPubMed
13.
14.
Nakamura T. Absolute risk for fracture and WHO guideline. Fracture risk assessments recommended by World Health Organization and Japanese guidelines for prevention and treatment of osteoporosis 2006. Clin Calcium. 2007;17(7):1022–8.PubMed
15.
Ha KYK. Risk factors affecting progressive collapse of acute osteoporotic spinal fractures. Osteoporos Int. 2013;24(4):1207–13.CrossRefPubMed
16.
Aspenberg P, Genant HK, Johansson T, Nino AJ, See K, Krohn K, Garcia-Hernandez PA, Recknor CP, Einhorn TA, Dalsky GP, et al. Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res. 2010;25(2):404–14.CrossRefPubMed
17.
Peichl P, Holzer LA, Maier R, Holzer G. Parathyroid hormone 1–84 accelerates fracture-healing in pubic bones of elderly osteoporotic women. J Bone Joint Surg Am. 2011;93A(17):1583–7.CrossRef
18.
Chintamaneni S, Finzel K, Gruber BL. Successful treatment of sternal fracture nonunion with teriparatide. Osteoporos Int. 2010;21(6):1059–63.CrossRefPubMed
19.
Rubery PT, Bukata SV. Teriparatide May accelerate healing in delayed unions of type III odontoid fractures a report of 3 cases. J Spinal Disord Tech. 2010;23(2):151–5.CrossRefPubMed
20.
Adami SS. The effect of age, weight, and lifestyle factors on calcaneal quantitative ultrasound: the ESOPO study. Osteoporos Int. 2003;14(3):198.CrossRefPubMed
21.
22.
23.
Heggeness MHM. Spine fracture with neurological deficit in osteoporosis. Osteoporos Int. 1993;3(4):215–21.CrossRefPubMed
24.
Kaneda K, Asano S, Hashimoto T, Satoh S, Fujiya M. The treatment of osteoporotic posttraumatic vertebral collapse using the kaneda device and a bioactive ceramic vertebral prosthesis. Spine. 1992;17(8):S295–303.CrossRefPubMed
25.
Kanayama M, Ishida T, Hashimoto T, Shigenobu K, Togawa D, Oha F, Kaneda K. Role of major spine surgery using kaneda anterior instrumentation for osteoporotic vertebral collapse. J Spinal Disord Tech. 2010;23(1):53–6.CrossRefPubMed
26.
Wu AM. Vertebral compression fracture with intravertebral vacuum cleft sign: pathogenesis, image, and surgical intervention. Asian spine J. 2013;7(2):148–55.CrossRefPubMedPubMedCentral
27.
Stäbler AA. Intravertebral vacuum phenomenon following fractures: CT study on frequency and etiology. J Comput Assist Tomogr. 1999;23(6):976–80.CrossRefPubMed
28.
Hayashi TT. Morphology of the injured posterior wall causing spinal canal encroachment in osteoporotic vertebral fractures. Spine J. 2016;16(8):946–50.CrossRefPubMed
29.
Freedman BA. Kummel disease: a not-so-rare complication of osteoporotic vertebral compression fractures. J Am Board Fam Med. 2009;22(1):75–8.CrossRefPubMed
30.
Hamano HH. Teriparatide improves trabecular osteoporosis but simultaneously promotes ankylosis of the spine in the Twy mouse model for diffuse idiopathic skeletal hyperostosis. Calcif Tissue Int. 2016;98(2):140–8.CrossRefPubMed
31.
Matsumoto TT. Effective treatment of delayed union of a lumbar vertebral fracture with daily administration of teriparatide in a patient with diffuse idiopathic skeletal hyperostosis. Eur Spine J. 2015;24 Suppl 4:573–6.CrossRef
32.
Nenonen AA. Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover. J Bone Miner Res. 2005;20(10):1804–12.CrossRefPubMed
33.
34.
Li HH. Kümmell’s disease, an uncommon and complicated spinal disorder: a review. J Int Med Res. 2012;40(2):406.CrossRefPubMed
35.
Kleerekoper MM. Assessing the effects of teriparatide treatment on bone mineral density, bone microarchitecture, and bone strength. J Bone Joint Surg (Am Vol). 2014;96(11):e90.CrossRef
36.
Graeff CC. Improvements in vertebral body strength under teriparatide treatment assessed in vivo by finite element analysis: results from the EUROFORS study. J Bone Miner Res. 2009;24(10):1672–80.CrossRefPubMed
Metadata
Title
Effect of teriparatide (rh-PTH 1–34) versus bisphosphonate on the healing of osteoporotic vertebral compression fracture: A retrospective comparative study
Authors
Akira Iwata
Masahiro Kanayama
Fumihiro Oha
Tomoyuki Hashimoto
Norimasa Iwasaki
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2017
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-017-1509-1

Other articles of this Issue 1/2017

BMC Musculoskeletal Disorders 1/2017 Go to the issue

Research article

Risk factors for joint replacement in knee osteoarthritis; a 15-year follow-up study

Research article

Single nucleotide polymorphisms in the CD40 gene associate with the disease susceptibility and severity in knee osteoarthritis in the Chinese Han population: a case-control study

Research article

Prediction of fracture load and stiffness of the proximal femur by CT-based specimen specific finite element analysis: cadaveric validation study

Research article

Correlation between intervertebral disc degeneration, paraspinal muscle atrophy, and lumbar facet joints degeneration in patients with lumbar disc herniation

Research article

Preferences and motivation for weight loss among knee replacement patients: implications for a patient-centered weight loss intervention

Research article

Developmental hip dysplasia treated by total hip arthroplasty using a cementless Wagner cone stem in young adult patients with a small physique